These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Cerebral infarction within six hours of onset: prediction of completed infarction with technetium-99m-HMPAO SPECT. Shimosegawa E; Hatazawa J; Inugami A; Fujita H; Ogawa T; Aizawa Y; Kanno I; Okudera T; Uemura K J Nucl Med; 1994 Jul; 35(7):1097-103. PubMed ID: 8014664 [TBL] [Abstract][Full Text] [Related]
28. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. Asenbaum S; Brücke T; Pirker W; Pietrzyk U; Podreka I J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665 [TBL] [Abstract][Full Text] [Related]
29. Reversible hypoperfusion of the cerebral cortex in normal-pressure hydrocephalus on technetium-99m-HMPAO brain SPECT images after shunt operation. Shih WJ; Tasdemiroglu E J Nucl Med; 1995 Mar; 36(3):470-3. PubMed ID: 7884512 [TBL] [Abstract][Full Text] [Related]
30. Technetium-99m-HMPAO brain SPECT in neonates with hypoglycemic encephalopathy. Chiu NT; Huang CC; Chang YC; Lin CH; Yao WJ; Yu CY J Nucl Med; 1998 Oct; 39(10):1711-3. PubMed ID: 9776274 [TBL] [Abstract][Full Text] [Related]
31. What is the predictive value of increased technetium-99m-HMPAO uptake for brain survival/necrosis in the acute stage of ischemic stroke? Baron JC; Marchal G J Nucl Med; 1995 Dec; 36(12):2392-4. PubMed ID: 8523137 [No Abstract] [Full Text] [Related]
32. An analysis of the arterial input curve for technetium-99m-HMPAO: quantification of rCBF using single-photon emission computed tomography. Pupi A; De Cristofaro MT; Bacciottini L; Antoniucci D; Formiconi AR; Mascalchi M; Meldolesi U J Nucl Med; 1991 Aug; 32(8):1501-6. PubMed ID: 1869968 [TBL] [Abstract][Full Text] [Related]
33. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Bonte FJ; Weiner MF; Bigio EH; White CL Radiology; 1997 Mar; 202(3):793-7. PubMed ID: 9051035 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of neuro-Behçet disease with 99mTc-HMPAO brain SPECT: comparison with MR imaging]. Kikuchi Y; Oshima M; Sasaki Y; Kaminaga T; Ban S; Shirai T; Yokokawa T; Higashi S; Yasukouchi H; Furui S Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):515-9. PubMed ID: 9267141 [TBL] [Abstract][Full Text] [Related]
35. Hyperperfusion and early technetium-99m-HMPAO SPECT appearance of central nervous system toxoplasmosis. Catafau AM; Solá M; Lomeña FJ; Guelar A; Miró JM; Setoain J J Nucl Med; 1994 Jun; 35(6):1041-3. PubMed ID: 8195866 [TBL] [Abstract][Full Text] [Related]
36. SPECT diagnosis of Creutzfeld-Jacob disease. Aharon-Peretz J; Peretz A; Hemli JA; Honigman S; Israel O J Nucl Med; 1995 Apr; 36(4):616-7. PubMed ID: 7699453 [TBL] [Abstract][Full Text] [Related]
37. [Preoperative evaluation of drug resistant focal epilepsies with 123I-iomazenil SPECT. Comparison with vidio/EEG monitoring and postoperative results]. Venz S; Cordes M; Straub HB; Hierholzer J; Schröder R; Richter W; Schmitz B; Meencke H; Felix R Nuklearmedizin; 1994 Oct; 33(5):189-93. PubMed ID: 7997376 [TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance. Ichise M; Chung DG; Wang P; Wortzman G; Gray BG; Franks W J Nucl Med; 1994 Feb; 35(2):217-26. PubMed ID: 8294988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]